Breast IHC Panel-ER, PR, HER2/neu (c-erb-B2)

51+ booked in last 3 days

No special precautions

Recommended for

Male, Female

Report

Within 24 Hours

Blood test at Home

NABL & CAP Accredited Labs

Accurate & Quality Test Reports

Trusted by Leading Doctors & Hospitals

Overview

Breast IHC Panel (ER, PR, C-erb-B2) are a group of tests used to assess the presence and amount of specific proteins in breast tissue samples. These proteins, estrogen receptor (ER), progesterone receptor (PR), and HER2/neu (C-erb-B2), are found on the surface of breast cancer cells and can play a role in the growth and spread of breast cancer.

Knowing the status of these proteins helps doctors determine the best course of treatment for breast cancer patients. For instance, if a tumor is ER-positive, it may respond well to hormone therapy medications that target the estrogen receptor. Similarly, HER2-positive tumors may benefit from targeted therapies that specifically block the HER2/neu protein.

Breast IHC Panel-ER, PR, HER2/neu (c-erb-B2) Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Breast IHC Panel-ER, PR, HER2/neu (c-erb-B2) with a clear pricing structure.

The Breast IHC Panel-ER, PR, HER2/neu (c-erb-B2) Price in Parel is ₹ 4,990 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

What does the ER, PR, C-erb-B2 IHC Panels test measure?

This test detects the presence of estrogen receptor (ER), progesterone receptor (PR), and c-erb-B2 proteins in breast tissue. These proteins are important for understanding the hormone status and aggressiveness of breast cancer.

Why is the ER, PR, C-erb-B2 IHC Panels test done?

To determine the hormone receptor status of breast cancer (whether the cancer cells have receptors for estrogen or progesterone)
To assess the aggressiveness of breast cancer
To guide treatment decisions for breast cancer

When is the ER, PR, C-erb-B2 IHC Panels test recommended and who should take it?

This test is recommended in the following situations:

Newly diagnosed breast cancer patients to determine hormone receptor status
For patients with recurrent or metastatic breast cancer to reassess hormone receptor status
As a follow-up test to monitor treatment response

What if the results of the ER, PR, C-erb-B2 IHC Panels test are abnormal?

Abnormal ER and PR levels indicate that hormone therapy may be beneficial in treating breast cancer. Abnormal c-erb-B2 levels may indicate a more aggressive form of breast cancer and the need for targeted therapy. Abnormal results may guide treatment decisions and further diagnostic tests. It is important to discuss the results with your doctor.

What to expect during the ER, PR, C-erb-B2 IHC Panels test?

A small sample of breast tissue will be collected.
The sample will be sent to the laboratory for analysis.
The laboratory will use a method called immunohistochemistry (IHC) to detect and measure the levels of ER, PR, and c-erb-B2 proteins in the tissue sample.

What preparations are required before the ER, PR, C-erb-B2 IHC Panels test?

Follow any specific instructions provided by your doctor regarding fasting or medication use.
Have any relevant medical reports or radiological images available for reference.

What other tests may be ordered with the ER, PR, C-erb-B2 IHC Panels test?

HER2 gene amplification test: To determine if breast cancer has an overexpression of HER2 protein
Ki-67: To assess the proliferation rate of breast cancer cells
Genetic testing for BRCA1 and BRCA2 mutations: To identify inherited gene mutations that increase the risk of developing breast cancer

What is the ER, PR, C-erb-B2 IHC Panels test also known as?

Breast Hormone Receptor Test
Estrogen receptor (ER) Test
Progesterone receptor (PR) Test
Her2/neu Test
c-erb-B2 Test

What is breast cancer?

Breast cancer is a type of cancer that forms in the cells of the breast. It can occur in both men and women, but it is more common in women. Breast cancer usually starts as a lump or mass in the breast tissue.

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.